IL6 and breast cancer: Co-treatment with LY294002 or WM prevented FLX-induced BC dilatation at all tested concentrations in HepaRG cells (Fig. 7B), and restored partially FLX-induced decrease in CDF and [3H]-TA efflux (Fig. 7C,D).